Patents by Inventor Stephen L. Monfre

Stephen L. Monfre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8504128
    Abstract: Sampling is controlled in order to enhance analyte concentration estimation derived from noninvasive sampling. More particularly, sampling is controlled using controlled fluid delivery to a region between a tip of a sample probe and a tissue measurement site. The controlled fluid delivery enhances coverage of a skin sample site with the thin layer of fluid. Delivery of contact fluid is controlled in terms of spatial delivery, volume, thickness, distribution, temperature, and/or pressure.
    Type: Grant
    Filed: April 24, 2008
    Date of Patent: August 6, 2013
    Assignee: GLT Acquisition Corp.
    Inventors: Thomas B. Blank, Stephen L. Monfre, Kevin H. Hazen, Timothy L. Ruchti, Christopher Slawinski, Sedar R. Brown
  • Patent number: 7787924
    Abstract: The invention involves the monitoring of a biological parameter through a compact analyzer. The preferred apparatus is a spectrometer based system that is attached continuously or semi-continuously to a human subject and collects spectral measurements that are used to determine a biological parameter in the sampled tissue. The preferred target analyte is glucose. The preferred analyzer is a near-IR based glucose analyzer for determining the glucose concentration in the body.
    Type: Grant
    Filed: January 3, 2006
    Date of Patent: August 31, 2010
    Assignee: Sensys Medical, Inc.
    Inventors: George M. Acosta, James R. Henderson, N. Alan Abul Haj, Timothy L. Ruchti, Stephen L. Monfre, Thomas B. Blank, Kevin H. Hazen
  • Patent number: 7697966
    Abstract: The invention provides a targeting system used to direct a measuring system to a targeted sample site or volume. The targeting system increases analyte estimation performance by increasing precision and accuracy of sampling and/or by targeting an analyte rich tissue volume.
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: April 13, 2010
    Assignee: Sensys Medical, Inc.
    Inventors: Stephen L. Monfre, Thomas B. Blank, Kevin H. Hazen, Alan Abul-Haj, Tim Ruchti, James Ryan Henderson, Tim Stippick, Roxanne Abul-Haj
  • Patent number: 7698105
    Abstract: The invention relates to noninvasive analyte property determination. More particularly, the invention relates to a method and apparatus for performing conditional additional acquisition of noninvasive spectra to improve analyzer performance. Conditional additional data acquisition is used to confirm, update, and/or supplement spectral data.
    Type: Grant
    Filed: June 27, 2005
    Date of Patent: April 13, 2010
    Assignee: Sensys Medical, Inc.
    Inventors: Timothy L. Ruchti, Linda Hockersmith, Stephen L. Monfre, Kevin H. Hazen
  • Publication number: 20090318786
    Abstract: Sampling is controlled in order to enhance analyte concentration estimation derived from noninvasive sampling. More particularly, sampling is controlled using controlled fluid delivery to a region between a tip of a sample probe and a tissue measurement site. The controlled fluid delivery enhances coverage of a skin sample site with the thin layer of fluid. Delivery of contact fluid is controlled in terms of spatial delivery, volume, thickness, distribution, temperature, and/or pressure.
    Type: Application
    Filed: April 25, 2008
    Publication date: December 24, 2009
    Inventors: Thomas B. BLANK, Timothy L. RUCHTI, Stephen L. MONFRE, Kevin H. HAZEN, Sedar BROWN, Christopher SLAWINSKI
  • Patent number: 7606608
    Abstract: An optical sampling interface system is disclosed that minimizes and compensates for errors that result from sampling variations and measurement site state fluctuations. Embodiments of the invention use a guide that does at least one of, induce the formation of a tissue meniscus, minimize interference due to surface irregularities, control variation in the volume of tissue sampled, use a two-part guide system, use a guide that controls rotation of a sample probe and allows z-axis movement of the probe, use a separate base module and sample module in conjunction with a guide, and use a guide that controls rotation. Optional components include an occlusive element and a coupling fluid.
    Type: Grant
    Filed: December 8, 2004
    Date of Patent: October 20, 2009
    Assignee: Sensys Medical, Inc.
    Inventors: Thomas B. Blank, George Acosta, Mutua Mattu, Marcy Makarewicz, Stephen L. Monfre, Alexander D. Lorenz, Timothy L. Ruchti, Kevin H. Hazen, Donovan D. Berry, Roxanne E. Abul-Haj
  • Publication number: 20090105669
    Abstract: A method and apparatus for cleaning a subject suffering from contracture provides a threaded and flexible cleaning tool for insertion between muscles joints or body parts suffering from contracture requiring no prying open of joints or minimally prying open of joints in order to facilitate cleaning of body parts otherwise obstructed by the contracture.
    Type: Application
    Filed: October 18, 2007
    Publication date: April 23, 2009
    Inventors: Patricia Rose Smigielski, Dorothy K. Monfre, Stephen L. Monfre
  • Publication number: 20090098587
    Abstract: A method of screening for disorders of glucose metabolism such as impaired glucose tolerance and diabetes allows prevention, or early detection and treatment of diabetic complications such as cardiovascular disease, retinopathy, and other disorders of the major organs and systems. A mathematical algorithm evaluates the shape of a subject's glucose profile and classifies the profile into one of several predefined clusters, each cluster corresponding either to a normal condition or one of several abnormal conditions. The series of blood glucose values making up the glucose tolerance curve may be measured using any glucose analyzer including: invasive, minimally invasive and noninvasive types. The method is executed on a processing device programmed to perform the steps of the method. Depending on the outcome of the screening, a subject may be provided with additional information concerning their condition and/or counseled to consult further with their health care provider.
    Type: Application
    Filed: April 8, 2008
    Publication date: April 16, 2009
    Applicant: SENSYS MEDICAL, INC.
    Inventors: Donald Hetzel, Stephen L. Monfre, Kevin H. Hazen, Timothy L. Ruchti, Thomas B. Blank, Linda Hockersmith, Andrew Cone
  • Patent number: 7509153
    Abstract: A method and apparatus for noninvasive glucose measurement measures glucose indirectly from the natural response of tissue to variations in analyte concentration. The indirect measurement method utilizes factors affected by or correlated with the concentration of glucose, such as refractive index, electrolyte distribution or tissue scattering. Measurement reliability is greatly improved by stabilizing optical properties of the tissue at the measurement site, thus blood perfusion rates at the sample site are regulated. Perfusion is monitored and stabilized by spectroscopically measuring a control parameter, such as skin temperature, that directly affects perfusion. The control parameter is maintained in a range about a set point, thus stabilizing perfusion. Skin temperature is controlled using a variety of means, including the use of active heating and cooling elements, passive devices, such as thermal wraps, and through the use of a heated coupling medium having favorable heat transfer properties.
    Type: Grant
    Filed: March 7, 2003
    Date of Patent: March 24, 2009
    Assignee: Sensys Medical, Inc.
    Inventors: Thomas B. Blank, Timothy L. Ruchti, Mutua Mattu, Marcy Makarewicz, Stephen L. Monfre, Alexander D. Lorenz
  • Patent number: 7505801
    Abstract: A placement guide apparatus with an improved hydration inducing plug used in coupling a noninvasive analyzer to a sampling site to determine analyte in the human body is disclosed. The hydration inducing plug includes at least one fluoropolymer that may be used as a coupling agent. The guide apparatus may further include an automated or semi-automated coupling fluid delivery system. Use of either of these couplers mitigates issues associated with related technology and enhances noninvasive analyte measurements, such as a near-IR diffuse reflectance based noninvasive glucose concentration analyzer.
    Type: Grant
    Filed: August 30, 2007
    Date of Patent: March 17, 2009
    Assignee: Sensys Medical, Inc.
    Inventors: Stephen L. Monfre, George M. Acosta, Thomas B. Blank, Kevin H. Hazen
  • Publication number: 20090036759
    Abstract: The invention relates generally to a noninvasive spectroscopic based analyzer. More particularly, a collapsible spectrometer and or deployable subject interface for an analyzer, such as a noninvasive glucose concentration analyzer, is described.
    Type: Application
    Filed: July 24, 2008
    Publication date: February 5, 2009
    Inventors: Timothy E. Ault, Stephen L. Monfre, Kevin H. Hazen
  • Publication number: 20080319382
    Abstract: Sampling is controlled in order to enhance analyte concentration estimation derived from noninvasive sampling. More particularly, sampling is controlled using controlled fluid delivery to a region between a tip of a sample probe and a tissue measurement site. The controlled fluid delivery enhances coverage of a skin sample site with the thin layer of fluid. Delivery of contact fluid is controlled in terms of spatial delivery, volume, thickness, distribution, temperature, and/or pressure.
    Type: Application
    Filed: April 24, 2008
    Publication date: December 25, 2008
    Inventors: Thomas B. Blank, Stephen L. Monfre, Kevin H. Hazen, Timothy L. Ruchti, Christopher Slawinski, Sedar R. Brown
  • Patent number: 7395158
    Abstract: A method of screening for disorders of glucose metabolism such as impaired glucose tolerance and diabetes allows prevention, or early detection and treatment of diabetic complications such as cardiovascular disease, retinopathy, and other disorders of the major organs and systems. A mathematical algorithm evaluates the shape of a subject's glucose profile and classifies the profile into one of several predefined clusters, each cluster corresponding either to a normal condition or one of several abnormal conditions. The series of blood glucose values making up the glucose tolerance curve may be measured using any glucose analyzer including: invasive, minimally invasive and noninvasive types. The method is executed on a processing device programmed to perform the steps of the method. Depending on the outcome of the screening, a subject may be provided with additional information concerning their condition and/or counseled to consult further with their health care provider.
    Type: Grant
    Filed: August 13, 2002
    Date of Patent: July 1, 2008
    Assignee: Sensys Medical, Inc.
    Inventors: Stephen L. Monfre, Linda Hockersmith, Donald Hetzel, Kevin H. Hazen, Andrew Cone
  • Patent number: 7333843
    Abstract: A placement guide apparatus with an improved hydration inducing plug used in coupling a noninvasive analyzer to a sampling site to determine analyte in the human body is disclosed. The hydration inducing plug includes at least one fluoropolymer that may be used as a coupling agent. The guide apparatus may further include an automated or semi-automated coupling fluid delivery system. Use of either of these couplers mitigates issues associated with related technology and enhances noninvasive analyte measurements, such as a near-IR diffuse reflectance based noninvasive glucose concentration analyzer.
    Type: Grant
    Filed: April 13, 2004
    Date of Patent: February 19, 2008
    Assignee: Sensys Medical, Inc.
    Inventors: Stephen L. Monfre, George Acosta, Thomas B. Blank, Kevin H. Hazen
  • Patent number: 7299080
    Abstract: A near IR spectrometer-based analyzer attaches continuously or semi-continuously to a human subject and collects spectral measurements for determining a biological parameter in the sampled tissue, such as glucose concentration. The analyzer includes an optical system optimized to target the cutaneous layer of the sampled tissue so that interference from the adipose layer is minimized. The optical system includes at least one optical probe. Spacing between optical paths and detection fibers of each probe and between probes is optimized to minimize sampling of the adipose subcutaneous layer and to maximize collection of light backscattered from the cutaneous layer. Penetration depth is optimized by limiting range of distances between paths and detection fibers. Minimizing sampling of the adipose layer greatly reduces interference contributed by the fat band in the sample spectrum, increasing signal-to-noise ratio.
    Type: Grant
    Filed: April 7, 2004
    Date of Patent: November 20, 2007
    Assignee: Sensys Medical, Inc.
    Inventors: George Acosta, James R. Henderson, N. Alan Abul-Haj, Timothy L. Ruchti, Stephen L. Monfre, Thomas B. Blank, Kevin H. Hazen
  • Patent number: 7233816
    Abstract: An optical sampling interface system minimizes and compensates error resulting from sampling variations and measurement site state fluctuations. Components include: An optical probe placement guide having an aperture wherein the optical probe is received, facilitates repeatable placement accuracy on surface of a tissue measurement site with minimal, repeatable disturbance to surface tissue. The aperture creates a tissue meniscus that minimizes interference due to surface irregularities and controls variation in tissue volume sampled; an occlusive element placed over the tissue meniscus isolates the meniscus from environmental fluctuations, stabilizing hydration at the site and thus, surface tension; an optical coupling medium eliminates air gaps between skin surface and optical probe; a bias correction element applies a bias correction to spectral measurements, and associated analyte measurements. When the guide is replaced, a new bias correction is determined for measurements done with the new placement.
    Type: Grant
    Filed: August 12, 2004
    Date of Patent: June 19, 2007
    Assignee: Sensys Medical, Inc.
    Inventors: Thomas B. Blank, George Acosta, Mutua Mattu, Marcy Makarewicz, Stephen L. Monfre, Alexander D. Lorenz, Timothy L. Ruchti
  • Patent number: 7206623
    Abstract: An optical sampling interface system minimizes and compensates error resulting from sampling variations and measurement site state fluctuations. Components include: An optical probe placement guide having an aperture wherein the optical probe is received, facilitates repeatable placement accuracy on surface of a tissue measurement site with minimal, repeatable disturbance to surface tissue. The aperture creates a tissue meniscus that minimizes interference due to surface irregularities and controls variation in tissue volume sampled; an occlusive element placed over the tissue meniscus isolates the meniscus from environmental fluctuations, stabilizing hydration at the site and thus, surface tension; an optical coupling medium eliminates air gaps between skin surface and optical probe; a bias correction element applies a bias correction to spectral measurements, and associated analyte measurements. When the guide is replaced, a new bias correction is determined for measurements done with the new placement.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: April 17, 2007
    Assignee: Sensys Medical, Inc.
    Inventors: Thomas B. Blank, George Acosta, Mutua Mattu, Marcy Makarewicz, Stephen L. Monfre, Alexander D. Lorenz, Timothy L. Ruchti
  • Patent number: 7183102
    Abstract: A method and apparatus for calibrating noninvasive or implantable glucose analyzers that uses either alternative invasive glucose determinations or noninvasive glucose determinations to calibrate noninvasive or implantable glucose analyzers. Use of an alternative invasive or noninvasive glucose determination in the calibration allows minimization of errors due to sampling methodology, and spatial and temporal variations that are built into the calibration model. An additional embodiment uses statistical correlations between noninvasive and alternative invasive glucose determinations and traditional invasive glucose determinations to adjust noninvasive or alternative invasive glucose concentrations to traditional invasive glucose concentrations. The invention provides a means for calibrating on the basis of glucose determinations that reflect the matrix observed and the variable measured by the analyzer more closely.
    Type: Grant
    Filed: May 4, 2005
    Date of Patent: February 27, 2007
    Assignee: Sensys Medical, Inc.
    Inventors: Stephen L. Monfre, Kevin H. Hazen, Timothy L. Ruchti, Thomas B. Blank, James R. Henderson
  • Patent number: 7133710
    Abstract: The invention involves the monitoring of a biological parameter through a compact analyzer. The preferred apparatus is a spectrometer based system that is attached continuously or semi-continuously to a human subject and collects spectral measurements that are used to determine a biological parameter in the sampled tissue. The preferred target analyze is glucose. The preferred analyzer is a near-IR based glucose analyzer for determining the glucose concentration in the body.
    Type: Grant
    Filed: March 7, 2003
    Date of Patent: November 7, 2006
    Assignee: Sensys Medical, Inc.
    Inventors: George M. Acosta, James R. Henderson, N. Alan Abul Haj, Timothy L. Ruchti, Stephen L. Monfre, Thomas B. Blank, Kevin H. Hazen
  • Patent number: RE41333
    Abstract: A method of multi-tier classification and calibration in noninvasive blood analyte prediction minimizes prediction error by limiting co-varying spectral interferents. Tissue samples are categorized based on subject demographic and instrumental skin measurements, including in vivo near-IR spectral measurements. A multi-tier intelligent pattern classification sequence organizes spectral data into clusters having a high degree of internal consistency in tissue properties. In each tier, categories are successively refined using subject demographics, spectral measurement information and other device measurements suitable for developing tissue classifications. The multi-tier classification approach to calibration utilizes multivariate statistical arguments and multi-tiered classification using spectral features.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: May 11, 2010
    Assignee: Sensys Medical, Inc.
    Inventors: Thomas B. Blank, Stephen L. Monfre, Timothy L. Ruchti, Suresh N. Thennadill